Epigral Limited Announces Board Meeting to Discuss First Quarter Financial Results
Epigral Limited has scheduled its Board of Directors meeting to review and take on record the company’s Un-audited Financial Results for the first quarter of the financial year. The meeting is set to take place on Monday, July 27, 2026, at the Registered Office of the Company.The primary focus of the board meeting will be the consideration of the Un-audited Financial Results, which encompass both Standalone and Consolidated figures for the First Quarter ending June 30, 2026. Additionally, directors are expected to review and approve the Limited Review Report prepared by the Statutory Auditors regarding these financial results.
In addition to discussing the quarterly performance and the auditor's findings, the agenda permits the Board to consider any other business that may be permitted by the Chair. The meeting is convened to ensure shareholders are informed of the company’s operational and financial status for the quarter.
EPIGRAL Stock Price Movement
As of 11:53 AM, shares of Epigral Limited are slipping by 3.32% in live trading, currently valued at ₹1125.5 as the stock sheds ₹38.70 in the current session. The equity is being traded on a volume of 47,384 shares.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.